Pharmacogenomic Testing to Select Antiplatelet Therapy

被引:9
作者
Price, Matthew J. [1 ]
Angiolillo, Dominick J. [2 ]
机构
[1] Scripps Clin, Div Cardiovasc Dis, 9898 Genesee Ave,AMP 200, La Jolla, CA 92037 USA
[2] Univ Florida, Div Cardiol, Jacksonville, FL USA
关键词
acute coronary syndrome; antiplatelet therapy; clopidogrel; pharmacogenomics; platelet function testing; platelet reactivity; prasugrel; thienopyridine; ticagrelor; PERCUTANEOUS CORONARY INTERVENTION; PLATELET REACTIVITY; DOSE CLOPIDOGREL; GENETIC POLYMORPHISMS; CLINICAL-OUTCOMES; RANDOMIZED-TRIAL; TICAGRELOR; PRASUGREL; STANDARD; IMPLANTATION;
D O I
10.1016/j.jacc.2018.03.021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1878 / 1881
页数:4
相关论文
共 20 条
  • [1] International Expert Consensus on Switching Platelet P2Y12 Receptor-Inhibiting Therapies
    Angiolillo, Dominick J.
    Rollini, Fabiana
    Storey, Robert F.
    Bhatt, Deepak L.
    James, Stefan
    Schneider, David J.
    Sibbing, Dirk
    So, Derek Y. F.
    Trenk, Dietmar
    Alexopoulos, Dimitrios
    Gurbel, Paul A.
    Hochholzer, Willibald
    De Luca, Leonardo
    Bonello, Laurent
    Aradi, Daniel
    Cuisset, Thomas
    Tantry, Udaya S.
    Wang, Tracy Y.
    Valgimigli, Marco
    Waksman, Ron
    Mehran, Roxana
    Montalescot, Gilles
    Franchi, Francesco
    Price, Matthew J.
    [J]. CIRCULATION, 2017, 136 (20) : 1955 - +
  • [2] Platelet Function and Genetic Testing
    Angiolillo, Dominick J.
    Ferreiro, Jose Luis
    Price, Matthew J.
    Kirtane, Ajay J.
    Stone, Gregg W.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (17) : S21 - S31
  • [3] Adenosine-Mediated Effects of Ticagrelor Evidence and Potential Clinical Relevance
    Cattaneo, Marco
    Schulz, Rainer
    Nylander, Sven
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (23) : 2503 - 2509
  • [4] Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention
    Cavallari, Larisa H.
    Lee, Craig R.
    Beitelshees, Amber L.
    Cooper-DeHoff, Rhonda M.
    Duarte, Julio D.
    Voora, Deepak
    Kimmel, Stephen E.
    McDonough, Caitrin W.
    Gong, Yan
    Dave, Chintan V.
    Pratt, Victoria M.
    Alestock, Tameka D.
    Anderson, R. David
    Alsip, Jorge
    Ardati, Amer K.
    Brott, Brigitta C.
    Brown, Lawrence
    Chumnumwat, Supatat
    Clare-Salzler, Michael J.
    Coons, James C.
    Denny, Joshua C.
    Dillon, Chrisly
    Elsey, Amanda R.
    Hamadeh, Issam S.
    Harada, Shuko
    Hillegass, William B.
    Hines, Lindsay
    Horenstein, Richard B.
    Howell, Lucius A.
    Jeng, Linda J. B.
    Kelemen, Mark D.
    Lee, Yee Ming
    Magvanjav, Oyunbileg
    Montasser, May
    Nelson, David R.
    Nutescu, Edith A.
    Nwaba, Devon C.
    Pakyz, Ruth E.
    Palmer, Kathleen
    Peterson, Josh F.
    Pollin, Toni I.
    Quinn, Alison H.
    Robinson, Shawn W.
    Schub, Jamie
    Skaar, Todd C.
    Smith, D. Max
    Sriramoju, Vindhya B.
    Starostik, Petr
    Stys, Tomasz P.
    Stevenson, James M.
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (02) : 181 - 191
  • [5] Bedside Monitoring to Adjust Antiplatelet Therapy for Coronary Stenting
    Collet, Jean-Philippe
    Cuisset, Thomas
    Range, Gregoire
    Cayla, Guillaume
    Elhadad, Simon
    Pouillot, Christophe
    Henry, Patrick
    Motreff, Pascal
    Carrie, Didier
    Boueri, Ziad
    Belle, Loic
    Van Belle, Eric
    Rousseau, Helene
    Aubry, Pierre
    Monsegu, Jacques
    Sabouret, Pierre
    O'Connor, Stephen A.
    Abtan, Jeremie
    Kerneis, Mathieu
    Saint-Etienne, Christophe
    Barthelemy, Olivier
    Beygui, Farzin
    Silvain, Johanne
    Vicaut, Eric
    Montalescot, Gilles
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (22) : 2100 - 2109
  • [6] Cytochrome P450 Genetic Polymorphisms and the Response to Prasugrel Relationship to Pharmacokinetic, Pharmacodynamic, and Clinical Outcomes
    Mega, Jessica L.
    Close, Sandra L.
    Wiviott, Stephen D.
    Shen, Lei
    Hockett, Richard D.
    Brandt, John T.
    Walker, Joseph R.
    Antman, Elliott M.
    Macias, William L.
    Braunwald, Eugene
    Sabatine, Marc S.
    [J]. CIRCULATION, 2009, 119 (19) : 2553 - U44
  • [7] Pharmacogenomic Approach to Selecting Antiplatelet Therapy in Patients With Acute Coronary Syndromes The PHARMCLO Trial
    Notarangelo, Francesca Maria
    Maglietta, Giuseppe
    Bevilacqua, Paola
    Cereda, Marco
    Merlini, Piera Angelica
    Villani, Giovanni Quinto
    Moruzzi, Paolo
    Patrizi, Giampiero
    Tagliazucchi, Guidantonio Malagolia
    Crocamo, Antonio
    Guidorossi, Angela
    Pigazzani, Filippo
    Nicosia, Elisa
    Paoli, Giorgia
    Bianchessi, Marco
    Comelli, Mario Angelo
    Caminiti, Caterina
    Ardissino, Diego
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (17) : 1869 - 1877
  • [8] Detecting a thienopyridine effect by platelet reactivity assessment and its implications for risk stratification
    Price, M. J.
    Baker, B. A.
    Jakubowski, J. A.
    Li, W.
    Heiselman, D. E.
    Angiolillo, D. J.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (04) : 560 - 563
  • [9] Onset and offset of platelet inhibition after high-dose Clopidogrel loading and standard daily therapy measured by a point-of-care assay in healthy volunteers
    Price, Matthew J.
    Coleman, Jacqueline L.
    Steinhubl, Steven R.
    Wong, Garrett B.
    Cannon, Christopher P.
    Teirstein, Paul S.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (05) : 681 - 684
  • [10] Influence of Genetic Polymorphisms on the Effect of High-and Standard-Dose Clopidogrel After Percutaneous Coronary Intervention The GIFT (Genotype Information and Functional Testing) Study
    Price, Matthew J.
    Murray, Sarah S.
    Angiolillo, Dominick J.
    Lillie, Elizabeth
    Smith, Erin N.
    Tisch, Rebecca L.
    Schork, Nicholas J.
    Teirstein, Paul S.
    Topol, Eric J.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (22) : 1928 - 1937